Antares Therapeutics is a startup based in the United States, most recent round Series A, 2 tracked investors.
Antares Therapeutics is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Antares Therapeutics is a biotechnology company developing first-in-class precision medicines targeting previously undruggable cancer and serious disease targets. The company leverages an integrated drug discovery platform combining advanced computational chemistry, predictive sciences, and experimental biology to develop transformative therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.